A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations
一项随机、多中心、开放标签研究，旨在比较阿法替尼单药治疗与联合HAD-B1治疗EGFR突变局部晚期或转移性非小细胞肺癌患者的安全性和有效性。
期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354241268231
Kwag, Eunbin; Kim, Soo-Dam; Shin, Seong-Hoon; Oak, Chulho; Park, So-Jung; Choi, Jun-Yong; Hoon Yoon, Seong; Kang, In-Cheol; Jeong, Mi-Kyung; Woo Lee, Hyun; Bang, Sun-Hwi; Son, Ji Woong; Lee, Sanghun; Kim, Seung Joon; Yoo, Hwa-Seung
